Why There’s No Such Thing as “The Cancer Diet”

Debbie Sweeney, BCHN, FDN-P, ONC · MamaSweeney Nutrition

Two people sit in the same infusion suite on the same Tuesday. Same diagnosis, same stage, same treatment plan.

One of them is thin and losing weight she can’t afford to lose. The other has gained steadily since her first cycle and has blood sugar that’s been creeping up for years. One had her digestive tract rebuilt by surgery. One takes a medication that interacts with foods the other eats freely.They both go home with the same photocopied handout.Here is something that may sound strange coming from a nutritionist: your diagnosis is the least individual thing in that room. It is the part you share with thousands of other people. Nearly everything else that determines how food will actually behave in your body is yours alone.

Two kinds of one-size-fits-all

Generic advice reaches you from two directions, and both of them mean well.

From the clinical side, the default is often some version of eat whatever you can tolerate, add calories however you can, here’s a case of nutrition shakes. That advice exists because malnutrition during treatment is a genuine danger and because there is very little time in a fifteen-minute visit.

From the internet side, the default is a single protocol applied to everyone. Keto for everyone. Juicing for everyone. No fruit for anyone. Usually delivered with great confidence by someone who knows nothing about you except that you have cancer.

Those two look like opposites. They are the same mistake in different clothing. Both start from the diagnosis and stop there.

You will sometimes be told there is “no evidence” for nutrition in cancer care. It is worth understanding what that phrase actually means, because it is doing more work than people realize.

Large trials are expensive. Research follows funding, and funding follows what can be patented and sold. A way of eating cannot be owned by anyone, which means no company has a financial reason to spend enormous sums proving it works. So the trials that would settle these questions largely have not been run — not because the questions were asked and answered, but because nobody stood to profit from asking them. The absence of a large trial tells you something about who pays for trials. It does not tell you the mechanism is not real.

That said, I am not going to oversell in the other direction either. If someone promises you that their particular protocol is proven to change survival, they are getting ahead of what anyone can honestly claim.

That gap is exactly why individual assessment matters, and it is worth understanding why the gap exists. A population study answers the question what happens, on average, to thousands of people who are nothing like one another? Averaging is what those studies do; it is the whole method. When two people respond in opposite directions, the average lands in the middle and describes neither of them. That is a useful question for public health. It is not your question.

Your question is what happens in your body, and that one can only be answered by looking at your body.

Ten things that make you different

My practice is built on the Ten Terrains, a framework from Dr. Nasha Winters and Jess Higgins Kelley’s The Metabolic Approach to Cancer. Think of it as a map of the ground the treatment is landing on. There are ten areas, and your diagnosis determines almost none of them.

Here is what each one changes about food. These are the reasons the same meal helps one person and works against another.

1. Genetics and epigenetics — broccoli

The protective compound in broccoli is processed by a family of enzymes, and a very common genetic variation changes how quickly your body clears it. Research in the United States has suggested people who carry the active version of one of these genes get more protection from crucifers. Research in Asian populations has found the opposite. I want to be honest that this contradiction has not been resolved. What is clear is that your genetics move the effect, and that how you cook broccoli matters as much as how much you eat, because the enzyme that releases the active compound is destroyed by hard boiling.

2. Blood sugar balance — the same bowl of rice

In a study that tracked continuous glucose in 800 people across nearly 47,000 meals, responses to identical meals varied so widely that the researchers concluded universal dietary rules have limited usefulness. Two people eat the same portion of rice. One barely moves. The other spikes and crashes two hours later. Neither of them is doing anything wrong. This is why I would rather look at your own numbers than hand you a carbohydrate target from a book.

3. Toxic burden — grapefruit

A compound in grapefruit rind permanently disables one of the main enzymes your intestine uses to process medications. If you take nothing, grapefruit is a citrus fruit. If you take a drug that depends on that enzyme, grapefruit is a pharmacological event you are delivering at breakfast. The same logic applies to how food is cooked and where it is sourced, which I treat as real exposure questions rather than marketing ones.

4. Microbiome and digestive function — soy and pomegranate

Soy contains a compound that only becomes its most active form if you happen to have the right gut bacteria, and only about 30 to 50 percent of people do. In one study of postmenopausal women, weekly soy was linked to lower breast density in the women who could make that conversion and higher breast density in the women who could not. Same food. Opposite direction. Pomegranate, walnuts, and berries work the same way. People sort into distinct groups, including a group that converts none of it.

There is a second soy question that has nothing to do with your gut, and it properly belongs to the toxic burden terrain above. Soybeans grown in this country are almost entirely herbicide-tolerant varieties. The share of U.S. soybean acreage planted with them climbed from about 7 percent in 1996 and has sat near 94 percent since 2014, and soy is the one major crop where herbicide tolerance is essentially the only engineered trait in use. These plants are bred specifically to survive being sprayed with glyphosate, which means the spraying is the design, not the exception. More recently, varieties tolerant to a second herbicide have been added alongside.

Whether the residue levels people actually consume cause harm is genuinely disputed, and I am not going to tell you that argument is settled. What I will tell you is that it is a real exposure question rather than a marketing one, and that of the three soy variables it is by far the easiest to control. If soy is going to be part of your plan, organic and certified non- GMO sourcing removes this question entirely.

Which leaves soy as three separate questions rather than one: can your microbiome convert it, does your hormone picture welcome it, and how was it grown. That is exactly why “is soy good for you?” has no answer — and why the headlines that promise one are usually selling something.

5. Immune function — raw sprouts

When your white counts are low, the question is not whether produce is healthy, it is whether a particular item carries a bacterial load. Here is something worth knowing, because it surprises most people: the restrictive “neutropenic diet” that strips out fresh fruits and vegetables has not been shown to reduce infections or deaths. One large transplant study found higher infection rates in the group following it. What is recommended instead is standard safe food handling. Raw sprouts, unpasteurized dairy, and raw fish are genuinely different from a washed apple, and treating them as the same category is how people end up afraid to eat anything.

6. Inflammation — antioxidants

This is where dose and timing decide everything. Blueberries are blueberries. High-dose antioxidant supplements during treatment are a different intervention entirely. In a randomized trial of 540 people with early-stage head and neck cancer, high-dose vitamin E started on the first day of radiation was linked to a higher rate of second cancers during the period people were taking it, and the beta-carotene arm was stopped early over safety concerns. Several other supplement-and-chemotherapy pairings carry similar cautions, though I will say plainly that some of those are demonstrated and many remain theoretical. Antioxidants from food: yes. Grams of them from a bottle during treatment: only with your oncology team.

7. Circulation and clotting — leafy greens

If you take a blood thinner, kale is not forbidden. Erratic kale is the problem. The instruction is consistency, not avoidance, and that is a nutrition instruction I can give you cleanly. If your platelets are low, the reverse question applies to concentrated fish oil and garlic supplements. And this is where I will repeat a standing rule of my practice: I do not suggest iron. If your physician has prescribed it, it stays exactly as prescribed.

8. Hormone balance — phytoestrogens

Soy returns here from a different angle, and flax behaves similarly. Whether your cancer is hormone-receptor positive, and which endocrine medication you take, change this conversation completely. One widely used medication has to be converted by your liver into its active form before it works at all, and several ordinary kitchen and supplement- shelf items can interfere with that conversion. Turmeric is on that list. So is valerian. Most people take both without ever mentioning them.

9. Stress and body rhythms — when you eat

In a study of 2,413 women with early-stage breast cancer, going less than 13 hours overnight without eating was associated with a higher recurrence rate than going 13 hours or more. Longer overnight gaps also tracked with better blood sugar markers and longer sleep. This was observational and based on self-reported recall, so I would not oversell it. But it is a nutrition lever that costs nothing, and it is a completely different lever from what goes on the plate.

10. Mental and emotional wellbeing — the avoid list

The example here is not a food. It is a piece of paper. Someone hands me a page of forty forbidden items collected from four different sources and tells me she is afraid to eat. That plan has already failed, no matter how defensible any single line on it might be. Same terrain: the person who stops mentioning her supplements to her oncologist because someone made her feel judged, turning a manageable question into a hidden risk. A plan you cannot live inside is not a plan.

Ten areas. Even sorting each one crudely into high, middle, and low would give tens of thousands of possible combinations. The handout assumes there is one.

Herbs: “natural” is not a safety category

The most useful thing I can tell you about herbs during treatment is that potency runs both directions. If a plant compound is strong enough to do something, it is strong enough to do something you did not intend.

Green tea is the clearest example. It is a perfectly reasonable beverage for many people. And for someone taking a particular myeloma drug, the main compound in green tea has been shown in laboratory and animal studies to physically bind to that drug and block it from killing cancer cells. Nothing about “green tea is healthy” is false. It is simply the wrong question.

The right question is never is this herb good? It is: good for whom, at what dose, in what form, alongside which medication, during which week of treatment.

Some herbs speed up how fast your body clears a drug, which can lower the amount actually reaching the cancer. Others slow it down, which can push it into the range where side effects worsen. St. John’s wort has been shown in human studies to cut blood levels of one chemotherapy drug by roughly 40 percent.

This is why, during active treatment, I keep supplement lists short, specific, and fully disclosed to your oncology team and pharmacist. Not because botanicals do nothing. Because they do something.

Carbohydrates: the question is whose, not whether

You have almost certainly heard that sugar feeds cancer. The slogan is crude, and crude slogans are easy to wave away. But there is something real underneath it, and the real version is far more useful than the bumper sticker.

Start with something you may have experienced yourself. If you have had a PET scan, you were injected with a radioactive form of glucose and then imaged to see where it collected. That scan works because tumor tissue takes up glucose at a dramatically higher rate than the tissue around it. We built an entire imaging technology on that fact.

But fuel is only half of it, and honestly the less interesting half. The more important story is signaling. Chronically elevated insulin and its close relative IGF-1 are growth messages. They tell cells to divide, they suppress the cleanup processes that clear damaged cells, and they travel everywhere in the body. They are also among the most responsive signals you have — they answer to what you ate this afternoon.

This is why blood sugar balance is the second of the Ten Terrains, and not a footnote. It sits upstream of inflammation, hormone balance, and body composition. Move it, and several other terrains move with it.

So no, carbohydrate load is not a neutral variable. What I cannot honestly tell you is that a specific named protocol has been proven in a large trial to extend survival, for the reasons in the section above. Those two statements are not in conflict, and I would rather you hear both from me than get only one of them somewhere else.

What is individual is where your own line sits. Recall those 800 people eating identical meals with wildly different glucose responses. A woman with a stable weight, low fasting insulin, and a well-functioning gut is simply not the same case as a woman whose blood sugar has been drifting upward for a decade. Same diagnosis, different starting terrain, different carbohydrate conversation.

In my practice I work from a plate that is roughly three-quarters vegetables and one- quarter clean protein, and I remove grains and legumes. That is a clinical position built on terrain reasoning and on what I consistently observe in my clients, and I will always tell you which of my recommendations rest on published trials and which rest on mechanism and clinical observation. You are entitled to know the difference.

What I will not do is hand you and the woman beside you the same carbohydrate number.

Protein: “enough” is not a fixed number

This is where I push hardest, because muscle is one of the few things nearly everyone should be actively defending. Losing muscle during treatment is linked to more complications after surgery, more toxicity from treatment, and shorter survival. It is not a cosmetic issue.

European clinical nutrition guidelines put protein needs in cancer at roughly 1.0 to 1.5 grams per kilogram of body weight per day. That range exists because the right number inside it is individual.

And the number is only a starting point. In advanced illness the body becomes resistant to building muscle, so the same amount of protein buys less than it would have a year ago. Kidney function, stomach acid, digestive enzymes, bile flow, and how protein is spread across the day all change how much of what you eat actually reaches your muscle. Two people can eat an identical 100 grams and end up in different places.

A word about weight, since it is the number everyone watches. Weight is a readout, not a lever. If it is moving on its own, the useful question is what is moving it — intake, absorption, symptoms getting in the way, something else — and that question belongs in front of your team early rather than late. Chasing the number itself rarely works.

Movement matters here too, and it matters a great deal. But what kind and how much is a question for your physician and, ideally, a rehabilitation specialist who has seen your imaging. That is outside my scope and I will not guess at it from a distance.

Fasting: three different things wearing one name

Fasting comes up in almost every consultation, usually because a well-meaning friend sent an article. It deserves a real answer, and the real answer is that three very different practices get called “fasting” and they do not carry the same evidence or the same risk.

The overnight window. In a study of 2,413 women with early-stage breast cancer, those who went less than 13 hours overnight without eating had a higher recurrence rate than those who went 13 hours or more. Longer overnight gaps also tracked with better blood sugar markers and longer sleep. The caveats are real — this was observational, based on what women remembered eating, and the average gap was already 12.5 hours, so it is a narrow comparison. But this is the lowest-risk version by a wide margin, and for most people it costs nothing but finishing dinner earlier.

A fasting-mimicking diet around chemotherapy. A trial randomized 131 women with a particular type of stage II or III breast cancer to a low-calorie fasting-mimicking diet for three days before and during chemotherapy. Side effects were no worse in the fasting group even though they skipped a steroid the other group received, and tumor response looked better among the women who actually stuck with it. But the trial did not meet its main goals, adherence was genuinely difficult, and a larger study is still running. Promising and unsettled. Not established.

Prolonged water fasting during treatment. No. Not outside a clinical trial.

Now the part that matters most, and it circles back to everything above. The trials themselves tell you who fasting is not for. That breast cancer study excluded anyone with diabetes and anyone underweight. Which means the published evidence for fasting during cancer care was generated in people who were neither thin nor diabetic — precisely the people least likely to be handed the idea by a friend.

From a nutrition standpoint, fasting is off the table if you are losing weight without meaning to, if you are underweight, if you are struggling to hit your protein, or if mouth sores or digestive problems are already limiting what you can get in. If you take insulin or another blood sugar medication, or if your medical team is managing frailty, that decision belongs with them, not with me.

So: the same practice is plausibly helpful for one person and clearly harmful for another, based on nothing about the tumor and everything about the host. That is this entire article in one topic.

So what actually applies to everyone?

A fair question after all of that. Yes, there are real universals. They are worth knowing precisely because they mark the floor that everything individual gets built on.

  1. Protect your muscle, and spread protein across the day. The target inside that 1.0 to 1.5 gram range is yours; the priority is not.
  2. Treat weight change as information, not as a target. If the number is moving on its own, something upstream is moving it, and that belongs in front of your team early.
  3. Ultra-processed food and alcohol earn nothing. This is one of the very few places where general health advice and cancer advice agree without qualification.
  4. Eat a variety of plants, adjusted to the gut you have this week. Variety feeds the microbiome. Texture, form, and fiber get modified around mouth sores, surgery, radiation, or a rough cycle — and modifying is not the same as eliminating.
  5. Practice food safety when your counts are low, rather than a restrictive diet. Wash your produce. Skip raw sprouts, unpasteurized dairy, and raw fish. Do not eliminate fresh food.
  6. Drink deliberately, especially around infusion days.
  7. Tell your oncology team and pharmacist about every supplement, herb, tea, and powder. Every one. This is the single highest-value safety habit available to you, and it is non-negotiable.
  8. Do not start an aggressive dietary protocol on your own mid-treatment. Fasting, severe restriction, and high-dose supplements all have real effects on how your medications work.
  9. When you eat is part of nutrition, not just what you eat. The overnight gap is the most accessible version of this.
  10. Test rather than guess. Which is the whole point.

There is an uncomfortable asymmetry in this list worth naming out loud: the universals are where the evidence is strongest, and the individual questions are where the evidence is thinnest. That is not an argument against individualizing. It is an argument for individualizing carefully — using your labs, your symptoms, your treatment schedule, and what actually happens when you change something, instead of loyalty to a protocol.

What to do with this

If you take one thing away, let it be this: when someone hands you a cancer diet, the right response is not does this work? but for whom?

And if you are currently holding a long list of forbidden foods that is making you afraid to eat, please know that the list itself is a problem worth solving. Fear is not a neutral ingredient. It belongs in the assessment alongside everything else.

The way I work through this with clients is a sequence, not a protocol:

Observe. What is actually happening — in your symptoms, your energy, your digestion, your weight, your labs.

Don’t guess. Resist the urge to act on a plausible story.

Test. Use functional lab work to see the terrain rather than infer it.

Address. Change one thing at a time, in the direction the findings point.

Discuss. Every piece of it, with the physicians and oncologists writing your prescriptions. My work sits alongside your treatment, never in place of it.

The tumor is what you are being treated for. The terrain is who is receiving the treatment. Nobody else has yours.

Debbie Sweeney, BCHN, FDN-P, ONC MamaSweeney Nutrition — Integrative Oncology & Functional Nutrition Terrain Over Tumor


This article is educational and is intended to complement conventional oncology care, not replace it. It is not individual medical advice and does not substitute for guidance from your treating physicians. Never start or stop a supplement, herb, or significant dietary change during treatment without clearing it with your oncology team.

The Ten Terrains framework referenced here is drawn from The Metabolic Approach to Cancer by Dr. Nasha Winters, ND, FABNO, and Jess Higgins Kelley, MNT.

Related posts

Cutting the Supply Lines: A Metabolic Approach to Angiogenesis & Metastasis — and How Food Helps Tip the Balance Back

By Debbie Sweeney, BCHN, FDN-P, ONC Two of the original hallmarks of cancer describe the moment a tumor stops being…

Read More
Blogs
Your Immune System & Deep Nutrition : A Patient-Friendly Guide for Cancer Patients & Survivors. Feeding the body that protects you.

By Debbie Sweeney, BCHN, FDNp, ONC If you have ever been told to “boost your immune system,” you have probably…

Read More

CancerBuddy Conversations

Meaningful conversations with survivors, caregivers, and experts. The CancerBuddy Conversation series brings together diverse voices in candid, uplifting dialogue—offering wisdom, shared experience, and real-life perspective from across the cancer community.

Learn More

Your contributions directly support cancer patients

With rising cancer rates, our work has never been more important. All donations for the Bone Marrow & Cancer Foundation go to services that directly help cancer patients, survivors, and families. The Foundation relies 100% on private donations. We depend on individual and corporate donors, as we don’t receive government or public funding. We offer innovative ways to contribute, and options for doubling the impact of donations. Thank you for your support, it means so much to so many patients.

Donate